Gradient AI Acquires Healthcare Analytics Business Unit from Prognos Health to Expand Medical Underwriting Offering

Integrated Offering Provides Group Healthcare Insurers Improved Risk Assessment through Access to Medical, Prescription and Lab Data on a Single Platform

Gradient AI, a leading enterprise software provider of artificial intelligence (AI) solutions in the insurance industry, announced that it has acquired Prognos Health’s analytics business underwriting unit to leverage data from the company’s large collection of integrated medical records and lab data via its real-world data marketplace.

Browse The Complete News About AI : Anari AI Launches Thor X to Enhance Cloud-based 3D Applications

“We are excited to join forces with Gradient AI to create a next-generation industry leading solution for group health insurance”

The acquisition will enable Gradient AI to expand its medical database capabilities by integrating Prognos Health’s data with SAIL™, Gradient AI’s leading medical underwriting solution. Medical records on 325 million de-identified U.S. patients can be accessed through the Prognos Marketplace.

In addition to retrieving medical and prescription claims data (capabilities Gradient AI already offers), customers will now have access to lab data, which has been a missing factor for many insurers when predicting group risk. According to the Centers for Disease Control and Prevention (CDC), 70% of today’s medical decisions depend on laboratory test results because they are among the best indicators of disease severity and progression.

With the acquisition, Gradient AI will become the only company in the group medical insurance market to provide medical, prescription, and lab data from a single source. Insurers will benefit by having further insight into group members’ health for more informed risk assessment and improved underwriting accuracy.

AI ML in Marketing: AI and Big Data Analysis Used to Find Brands’ Emotional Connection

“The acquisition of Prognos underwriting business unit is a game changer. Our combined solution will provide a holistic picture of group health risk that has never before been possible,” said Stan Smith, CEO and founder, Gradient AI. “Insurers will now have a single point of access to multiple data sources, covering medical, prescription and lab data improving their abilities to project group health assessments and costs with much greater confidence.”

Gradient AI aspires to continue its innovation in assessing group health risks. In the future, the company plans to expand its data sources to include information from Electronic Health Records (EHRs) and claims-based patient population data.

“We are excited to join forces with Gradient AI to create a next-generation industry leading solution for group health insurance,” said Sundeep Bhan, co-founder and CEO, Prognos Health. “Gradient AI is a clear leader in healthcare analytics underwriting. Prognos looks forward to supporting the rapid innovation at Gradient AI by leveraging the most relevant data from the Prognos Marketplace. With the sale of the underwriting business unit, Prognos will continue to focus on our real-word data marketplace and democratizing data to improve health.”